4//SEC Filing
OncoCyte Corp 4
Accession 0001209191-16-100262
$IMDXCIK 0001642380operating
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:33 PM ET
Size
6.7 KB
Accession
0001209191-16-100262
Insider Transaction Report
Form 4
Redmond Cavan M.
Director
Transactions
- Award
Option to Purchase Common Stock
2016-02-16+20,000→ 20,000 totalExercise: $3.06Exp: 2026-02-15→ Common Stock (20,000 underlying)
Holdings
- 10,000
Option to Purchase Common Stock
Exercise: $3.16Exp: 2025-09-08→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Will become exercisable in four equal installments at the end of each calendar quarter based upon continued service on the board of directors from the date of grant.
- [F2]2,500 options became exercisable on September 30, 2015 and December 31, 2015, and the remaining 5,000 options will become exercisable in 2 equal quarterly installments based upon continued service on the board of directors.
Documents
Issuer
OncoCyte Corp
CIK 0001642380
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001642380
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:33 PM ET
- Size
- 6.7 KB